These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

165 related items for PubMed ID: 10397612

  • 21. Polyspecific organic anion transporting polypeptides mediate hepatic uptake of amphipathic type II organic cations.
    van Montfoort JE, Hagenbuch B, Fattinger KE, Müller M, Groothuis GM, Meijer DK, Meier PJ.
    J Pharmacol Exp Ther; 1999 Oct; 291(1):147-52. PubMed ID: 10490898
    [Abstract] [Full Text] [Related]

  • 22. Involvement of multiple transporters in the efflux of 3-hydroxy-3-methylglutaryl-CoA reductase inhibitors across the blood-brain barrier.
    Kikuchi R, Kusuhara H, Abe T, Endou H, Sugiyama Y.
    J Pharmacol Exp Ther; 2004 Dec; 311(3):1147-53. PubMed ID: 15292460
    [Abstract] [Full Text] [Related]

  • 23. Substrate specificity of the rat liver Na(+)-bile salt cotransporter in Xenopus laevis oocytes and in CHO cells.
    Schroeder A, Eckhardt U, Stieger B, Tynes R, Schteingart CD, Hofmann AF, Meier PJ, Hagenbuch B.
    Am J Physiol; 1998 Feb; 274(2):G370-5. PubMed ID: 9486191
    [Abstract] [Full Text] [Related]

  • 24. Functional involvement of rat organic anion transporter 3 (rOat3; Slc22a8) in the renal uptake of organic anions.
    Hasegawa M, Kusuhara H, Sugiyama D, Ito K, Ueda S, Endou H, Sugiyama Y.
    J Pharmacol Exp Ther; 2002 Mar; 300(3):746-53. PubMed ID: 11861777
    [Abstract] [Full Text] [Related]

  • 25. The HMG-CoA reductase inhibitor pravastatin stimulates insulin secretion through organic anion transporter polypeptides.
    Abe M, Toyohara T, Ishii A, Suzuki T, Noguchi N, Akiyama Y, Shiwaku HO, Nakagomi-Hagihara R, Zheng G, Shibata E, Souma T, Shindo T, Shima H, Takeuchi Y, Mishima E, Tanemoto M, Terasaki T, Onogawa T, Unno M, Ito S, Takasawa S, Abe T.
    Drug Metab Pharmacokinet; 2010 Mar; 25(3):274-82. PubMed ID: 20610886
    [Abstract] [Full Text] [Related]

  • 26. Uptake of the mycotoxin ochratoxin A in liver cells occurs via the cloned organic anion transporting polypeptide.
    Kontaxi M, Echkardt U, Hagenbuch B, Stieger B, Meier PJ, Petzinger E.
    J Pharmacol Exp Ther; 1996 Dec; 279(3):1507-13. PubMed ID: 8968376
    [Abstract] [Full Text] [Related]

  • 27. Functional characterization of the mouse organic-anion-transporting polypeptide 2.
    van Montfoort JE, Schmid TE, Adler ID, Meier PJ, Hagenbuch B.
    Biochim Biophys Acta; 2002 Aug 19; 1564(1):183-8. PubMed ID: 12101011
    [Abstract] [Full Text] [Related]

  • 28. Transport mechanism of 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors at the blood-brain barrier.
    Tsuji A, Saheki A, Tamai I, Terasaki T.
    J Pharmacol Exp Ther; 1993 Dec 19; 267(3):1085-90. PubMed ID: 8263769
    [Abstract] [Full Text] [Related]

  • 29. Multispecific amphipathic substrate transport by an organic anion transporter of human liver.
    Bossuyt X, Müller M, Meier PJ.
    J Hepatol; 1996 Nov 19; 25(5):733-8. PubMed ID: 8938553
    [Abstract] [Full Text] [Related]

  • 30. Molecular characterization and tissue distribution of a new organic anion transporter subtype (oatp3) that transports thyroid hormones and taurocholate and comparison with oatp2.
    Abe T, Kakyo M, Sakagami H, Tokui T, Nishio T, Tanemoto M, Nomura H, Hebert SC, Matsuno S, Kondo H, Yawo H.
    J Biol Chem; 1998 Aug 28; 273(35):22395-401. PubMed ID: 9712861
    [Abstract] [Full Text] [Related]

  • 31. The transporter for the HMG-CoA reductase inhibitor pravastatin is not present in Hep G2 cells. Evidence for the nonidentity of the carrier for pravastatin and certain transport systems for BSP.
    Ziegler K, Blumrich M, Hummelsiep S.
    Biochim Biophys Acta; 1994 Sep 08; 1223(2):195-201. PubMed ID: 8086488
    [Abstract] [Full Text] [Related]

  • 32. Transporter-mediated influx and efflux mechanisms of pitavastatin, a new inhibitor of HMG-CoA reductase.
    Fujino H, Saito T, Ogawa S, Kojima J.
    J Pharm Pharmacol; 2005 Oct 08; 57(10):1305-11. PubMed ID: 16259759
    [Abstract] [Full Text] [Related]

  • 33. The disposition of pravastatin in a rat model of streptozotocin-induced diabetes and organic anion transporting polypeptide 2 and multidrug resistance-associated protein 2 expression in the liver.
    Hasegawa Y, Kishimoto S, Shibatani N, Inotsume N, Takeuchi Y, Fukushima S.
    Biol Pharm Bull; 2010 Oct 08; 33(1):153-6. PubMed ID: 20045956
    [Abstract] [Full Text] [Related]

  • 34. The role of hepatic transport and metabolism in the interactions between pravastatin or repaglinide and two rOatp inhibitors in rats.
    Badolo L, Bundgaard C, Garmer M, Jensen B.
    Eur J Pharm Sci; 2013 Jul 16; 49(4):767-72. PubMed ID: 23648783
    [Abstract] [Full Text] [Related]

  • 35. Identification of organic anion transporting polypeptide 4 (Oatp4) as a major full-length isoform of the liver-specific transporter-1 (rlst-1) in rat liver.
    Cattori V, Hagenbuch B, Hagenbuch N, Stieger B, Ha R, Winterhalter KE, Meier PJ.
    FEBS Lett; 2000 Jun 02; 474(2-3):242-5. PubMed ID: 10838093
    [Abstract] [Full Text] [Related]

  • 36. Characterization of the efflux transport of 17beta-estradiol-D-17beta-glucuronide from the brain across the blood-brain barrier.
    Sugiyama D, Kusuhara H, Shitara Y, Abe T, Meier PJ, Sekine T, Endou H, Suzuki H, Sugiyama Y.
    J Pharmacol Exp Ther; 2001 Jul 02; 298(1):316-22. PubMed ID: 11408557
    [Abstract] [Full Text] [Related]

  • 37. Localization of organic anion transporting polypeptide 4 (Oatp4) in rat liver and comparison of its substrate specificity with Oatp1, Oatp2 and Oatp3.
    Cattori V, van Montfoort JE, Stieger B, Landmann L, Meijer DK, Winterhalter KH, Meier PJ, Hagenbuch B.
    Pflugers Arch; 2001 Nov 02; 443(2):188-95. PubMed ID: 11713643
    [Abstract] [Full Text] [Related]

  • 38. Influence of non-steroidal anti-inflammatory drugs on organic anion transporting polypeptide (OATP) 1B1- and OATP1B3-mediated drug transport.
    Kindla J, Müller F, Mieth M, Fromm MF, König J.
    Drug Metab Dispos; 2011 Jun 02; 39(6):1047-53. PubMed ID: 21389119
    [Abstract] [Full Text] [Related]

  • 39. Simvastatin but not pravastatin is very susceptible to interaction with the CYP3A4 inhibitor itraconazole.
    Neuvonen PJ, Kantola T, Kivistö KT.
    Clin Pharmacol Ther; 1998 Mar 02; 63(3):332-41. PubMed ID: 9542477
    [Abstract] [Full Text] [Related]

  • 40. Immunohistochemical distribution and functional characterization of an organic anion transporting polypeptide 2 (oatp2).
    Kakyo M, Sakagami H, Nishio T, Nakai D, Nakagomi R, Tokui T, Naitoh T, Matsuno S, Abe T, Yawo H.
    FEBS Lett; 1999 Feb 26; 445(2-3):343-6. PubMed ID: 10094486
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.